NorthWest Biotherapeutics Inc (NWBO)

[rayenriq2103]

I agree flipper44. This is what I said on my post #231149:
My guess will be Monday 9/16/19. This is why - the last day of 2019 SNO's late breaking submittal is 9/1/19. From SNO's website "Authors will be notified within two weeks of the September 1st deadline if their abstract has been accepted for presentation". Similar to AMRN, NWBO will publish their result on the Neuro Oncology Journal and will present orally at the SNO conference (Nov 20-24) in Phoenix.

Sept 1 gives NWBO 3 months for the submittal of the SAP, reviewed/blessed by the FDA, data lock, final analysis for Topline.

LP's comment from the 2/2/19 ASM:
We were subjected to excruciating pressure to go to data-lock and finish the trial. Long before the data we reported last November. That data was presented in a plenary session at the Society for Neuro-Oncology, the biggest meeting of Neuro-Oncology subjects in the world. That's a big deal.

Mic drop....